UCSF research shows psychedelics like psilocybin may treat depression, Parkinson’s, and addiction, offering new hope in ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. LSD is being tested as a ...

Encouraging outcomes from a clinical study on the LSD-analog substance MM120, or lysergide d-tartrate, have led the Food and Drug Administration (FDA) to designate it as a “breakthrough therapy” for ...

For generations, America’s veterans have borne not only the visible scars of battle but also the hidden wounds of war.

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

A new study suggests that low doses of the psychedelic drug lysergic acid diethylamide, better known as LSD, can enhance how ...

MindMed's LSD tartrate receives breakthrough therapy designation from the FDA for the treatment of generalized anxiety disorder. GAD affects a significant portion of the US population, with high costs ...

MindMed Inc. said Tuesday it’s on track to launch Phase 3 clinical trials with up to 440 people starting later this year for its treatment of generalized anxiety disorder (GAD) through use of ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Catalent shows Catalent's MindMed's formulation of LSD. (Catalent via AP) WASHINGTON (AP) — LSD reduced ...